WO2001039725A3 - Drug preparations - Google Patents
Drug preparations Download PDFInfo
- Publication number
- WO2001039725A3 WO2001039725A3 PCT/US2000/041961 US0041961W WO0139725A3 WO 2001039725 A3 WO2001039725 A3 WO 2001039725A3 US 0041961 W US0041961 W US 0041961W WO 0139725 A3 WO0139725 A3 WO 0139725A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug preparations
- compositions
- preparations
- drug
- semisolid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00992485A EP1231897A2 (en) | 1999-11-08 | 2000-11-08 | Drug preparations |
CA002390841A CA2390841A1 (en) | 1999-11-08 | 2000-11-08 | Drug preparations |
AU45042/01A AU4504201A (en) | 1999-11-08 | 2000-11-08 | Drug preparations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16414999P | 1999-11-08 | 1999-11-08 | |
US60/164,149 | 1999-11-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001039725A2 WO2001039725A2 (en) | 2001-06-07 |
WO2001039725A3 true WO2001039725A3 (en) | 2002-05-10 |
Family
ID=22593194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/041961 WO2001039725A2 (en) | 1999-11-08 | 2000-11-08 | Drug preparations |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1231897A2 (en) |
AU (1) | AU4504201A (en) |
CA (1) | CA2390841A1 (en) |
WO (1) | WO2001039725A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005079824A1 (en) * | 2004-02-25 | 2005-09-01 | Hidemoto Kusaka | Beverage or drug containing bamboo extract as main ingredient |
US7972636B2 (en) | 2004-02-25 | 2011-07-05 | Hidemoto Kusaka | Beverage and medicament containing bamboo extract as a main ingredient |
WO2009091622A1 (en) * | 2008-01-18 | 2009-07-23 | Dow Global Technologies Inc. | Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5059123A (en) * | 1990-05-14 | 1991-10-22 | Jernberg Gary R | Periodontal barrier and method for aiding periodontal tissue regeneration |
US5783214A (en) * | 1994-06-13 | 1998-07-21 | Buford Biomedical, Inc. | Bio-erodible matrix for the controlled release of medicinals |
-
2000
- 2000-11-08 EP EP00992485A patent/EP1231897A2/en not_active Withdrawn
- 2000-11-08 AU AU45042/01A patent/AU4504201A/en not_active Abandoned
- 2000-11-08 WO PCT/US2000/041961 patent/WO2001039725A2/en not_active Application Discontinuation
- 2000-11-08 CA CA002390841A patent/CA2390841A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5059123A (en) * | 1990-05-14 | 1991-10-22 | Jernberg Gary R | Periodontal barrier and method for aiding periodontal tissue regeneration |
US5783214A (en) * | 1994-06-13 | 1998-07-21 | Buford Biomedical, Inc. | Bio-erodible matrix for the controlled release of medicinals |
Also Published As
Publication number | Publication date |
---|---|
CA2390841A1 (en) | 2001-06-07 |
WO2001039725A2 (en) | 2001-06-07 |
EP1231897A2 (en) | 2002-08-21 |
AU4504201A (en) | 2001-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
WO1999053910A3 (en) | Folic acid-containing pharmaceutical compositions, and related methods and delivery systems | |
HK1048801B (en) | Phenoxy carboxylic acid compounds and compositions for delivering active agents | |
WO2002070438A3 (en) | Compositions for delivering bisphosphonates | |
AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
NZ524138A (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
WO2000040203A3 (en) | Polymeric delivery agents and delivery agent compounds | |
EP1391200A4 (en) | Drug preparations | |
CA2408142A1 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MX9700885A (en) | New heteroaryloxazolidinones. | |
IL148288A0 (en) | Indolealkanol ester and indolealkylamide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
ZA200106104B (en) | Pharmaceutical composition containing proton pump inhibitors. | |
AU3850600A (en) | Dalda analogs and their use | |
MXPA03007857A (en) | Compounds and compositions for delivering active agents. | |
WO2002015959A3 (en) | Compounds and compositions for delivering active agents | |
MY132911A (en) | Clear, injectable solution of an anesthetic compound | |
MY133112A (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use | |
EP1092431A3 (en) | Lasofoxifene compositions | |
WO2002000208A3 (en) | Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents | |
WO2001039725A3 (en) | Drug preparations | |
AU9270598A (en) | Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates | |
ZA200110244B (en) | Novel xanthone compounds, their preparation and use as medicament. | |
AU6027899A (en) | Local delivery of medications to the heart | |
AU7028598A (en) | Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol | |
EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WPC | Withdrawal of priority claims after completion of the technical preparations for international publication | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2390841 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000992485 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000992485 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000992485 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |